SEQUENT SCIENTIFIC
Back to Balance Sheet
|
SEQUENT SCIENTIFIC Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹1,572 Cr | ₹1,531 Cr | ₹1,484 Cr | ₹1,487 Cr | ₹1,443 Cr |
What is the latest Total Liabilities ratio of SEQUENT SCIENTIFIC ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹1,572 Cr |
| Mar2024 | ₹1,531 Cr |
| Mar2023 | ₹1,484 Cr |
| Mar2022 | ₹1,487 Cr |
| Mar2021 | ₹1,443 Cr |
How is Total Liabilities of SEQUENT SCIENTIFIC Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,572 Cr | 2.68 | |
| Mar2024 | ₹1,531 Cr | 3.19 | |
| Mar2023 | ₹1,484 Cr | -0.19 | |
| Mar2022 | ₹1,487 Cr | 3.02 | |
| Mar2021 | ₹1,443 Cr | - | |
Compare Total Liabilities of peers of SEQUENT SCIENTIFIC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SEQUENT SCIENTIFIC | ₹9,102.8 Cr | -0.8% | 8.6% | 43.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹399,549.0 Cr | -1.9% | -7.3% | -2.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,862.0 Cr | 1.8% | 3.3% | 9.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,912.0 Cr | -0.5% | -4% | 29.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,891.0 Cr | 0.2% | -4.9% | 6.6% | Stock Analytics | |
| CIPLA | ₹99,591.5 Cr | 0.5% | -3.8% | -17% | Stock Analytics | |
SEQUENT SCIENTIFIC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SEQUENT SCIENTIFIC | -0.8% |
8.6% |
43.7% |
| SENSEX | 3.2% |
5% |
5.5% |
You may also like the below Video Courses